Immatics N.V.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Immatics N.V.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation: Netherlands
Headquarters city: Tubingen
Headquarters country: Germany
Fiscal year end: December
Ticker symbol: IMTX
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001809196

Board of directors

Follow this board

Adam Leo Stone · Director
Since 2026
Alise Reicin · Director
Since 2026
Eliot Forster · Director
Since 2026
Heather L. Mason · Director
Since 2026
Jasuja Harpreet Singh · Director · Chief Executive Officer
Since 2026
Joseph Edelman · Director Overboarded
Since 2026
Mathias Hothum · Director
Since 2026
Michael G. Atieh · Director
Since 2026
Paul Rutherford Carter · Director
Since 2026
Peter Alan Chambre · Director
Since 2026

Chief executives

Jasuja Harpreet Singh · Chief Executive Officer

Since March 2026

Board connections

5 of this board's directors also sit on 12 other boards. 10 are in the same sector.

Shared director Other board Same sector

Freenome Inc. Same sector
via Adam Leo Stone and Joseph Edelman
Solid Biosciences Inc. Same sector
via Adam Leo Stone and Joseph Edelman
Adagio Medical Holdings Inc Same sector
via Joseph Edelman
Chubb Limited
via Michael G. Atieh
Kardigan Inc. Same sector
via Joseph Edelman
LeonaBio Inc. Same sector
via Joseph Edelman
MeiraGTx Holdings plc Same sector
via Joseph Edelman
Nautilus Biotechnology Inc.
via Joseph Edelman
Protalix BioTherapeutics Inc. (DE) Same sector
via Eliot Forster
Q32 Bio Inc. Same sector
via Alise Reicin
Sana Biotechnology Inc. Same sector
via Alise Reicin
Tectonic Therapeutic Inc. Same sector
via Alise Reicin

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $7,499,991; 1 purchase by 1 insider
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Aug 26, 2026	Joseph Edelman Director	Open-market purchase	+863,060	$8.69	$7,499,991

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

BioNTech SE American Depositary Share Nasdaq: BNTX · Mainz, Germany Organization Fresenius Medical Care AG NYSE: FMS · BAD Homburg, Germany Organization 3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization

Questions about Immatics N.V.

Who is the CEO of Immatics N.V.?

Jasuja Harpreet Singh has been Immatics N.V.'s Chief Executive Officer since March 2026.

How many directors are on Immatics N.V.'s board?

Immatics N.V.'s board has 10 directors: Adam Leo Stone, Alise Reicin, Eliot Forster, Heather L. Mason, Jasuja Harpreet Singh, Joseph Edelman, Mathias Hothum, Michael G. Atieh, Paul Rutherford Carter and Peter Alan Chambre.

Are Immatics N.V. insiders buying or selling shares?

Over the last 12 months, Immatics N.V. insiders bought $7.5 million of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Immatics N.V. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="immatics-nv"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.